Catalent
CTLT
#1571
Rank
NZ$18.35 B
Marketcap
$101.10
Share price
0.73%
Change (1 day)
70.86%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$8.42 Billion

According to Catalent's latest financial reports the company's total debt is NZ$8.42 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30NZ$8.01 B18.28%
2022-06-30NZ$6.77 B45.35%
2021-06-30NZ$4.65 B-1.25%
2020-06-30NZ$4.71 B7.19%
2019-06-30NZ$4.40 B9.56%
2018-06-30NZ$4.01 B41.24%
2017-06-30NZ$2.84 B8.94%
2016-06-30NZ$2.61 B-5.04%
2015-06-30NZ$2.75 B-10.96%
2014-06-30NZ$3.08 B-11.14%
2013-06-30NZ$3.47 B3.95%
2012-06-30NZ$3.34 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$65 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.57 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.56 B 25.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$0.38 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA